People · Operator
Named in public records as an officer, director or promoter · active 2010–2017 · Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| iWalk, Inc. | — | Other Health Care | Series B | $74.5M | $377.9M | 2010 |
| Bionik Laboratories Corp. | — | Other Health Care | Series B | $41.3M | $27.7M | 2017 |
| Wentworth Technology, Inc. | — | Other Technology | Seed | $4.1M | $14.4M | 2010 |
Timothy McCarthy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Timothy McCarthy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Simon | 1 | 11 |
| William F. Doyle | 1 | 8 |
| Paul Flanagan | 1 | 6 |
| Geoff Pardo | 1 | 6 |
| Charles Moore | 1 | 5 |
| Robert Hariri | 1 | 5 |
| Richard Schotte | 1 | 4 |
| Peter Bloch | 1 | 4 |
| Kevin Connors | 1 | 4 |
| Charles Carignan | 1 | 3 |
| Michael Ellenbogen | 1 | 3 |
| Nathaniel Henshaw | 1 | 3 |
| Ian J. Vawter | 1 | 2 |
| William Sahlman | 1 | 2 |
| Brian Rigney | 1 | 2 |
| Michal Prywata | 1 | 2 |
| Paul J. Flanagan | 1 | 2 |
| Leslie Markow | 1 | 2 |
| Richard Cassell | 1 | 1 |
| Lisa Keslar | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.